exam 2 menstruation pp Flashcards
contraception prevents pregnancy by 1 of 3 ways
preventing ovulation
preventing implantation of fertilized ovum in the endometrium
inhibiting contact of sperm with mature ovum
most common coc contraindications
breastfeeding
shortly postpartum
women > 35 y/o who smoke >15 cigs/day
severe HTN
known thrombogenic history
migraine with aura
current or recent breast cancer
MEC category 3 and 4
Smoker who is > 35 years old
◦ Severe cirrhosis/liver tumors
◦ History of DVT or PE
◦ Major surgery with prolonged immobilization
◦ Migraine with aura
◦ Hypertension (even if controlled)
◦ Vascular disease
◦ Ischemic heart disease
◦ Multiple risk factors for ASCVD: older age, smoking,
diabetes, HTN, low HDL, high LDL, or high
triglycerides
◦ Stroke or history of stroke/CVA
◦ Breastfeeding
◦ Postpartum (0-42 days)
◦ Bariatric surgery patients who have malabsorption
(no COC’s)
◦ Current nephrotic syndrome
◦ Hemodialysis
◦ Lupus with antiphospholipid antibodies
◦ Multiples Sclerosis with prolonged immobility
◦ Breast cancer (w/i 5 yrs)
◦ Diabetic retinopathy, nephropathy, and/or
neuropathy
◦ Diabetes of > 20 years duration
◦ Current gallbladder disease
◦ Sickle Cell Disease
◦ Thrombophilia
additional goals of therapy
decreases PMDD symptoms
improved dysmenorrhea
menstrual cycle regularity
decreased acne and hirsutism
management of endometriosis and PCOS
PMDD symptoms
PMS symptoms: bloating, HA, breast tenderness
plus: extreme irritability, anxiety, depression, mood swings, insomnia, binge eating
MOA progestin
block LH surge that stimulates ovulation, and provides most of the contraceptive effects
prevents ovulation
thickens cervical mucus
slows sperm motility
endometrial atrophy
MOA estrogen
provides menstrual cycle control
prevents FSH release
stops recruitment and stimulation of follicles
provides stabilization to endometrial lining
follicular phase
day 1-14
first day of menses
continues through ovulation
days 1-4
FSH rises and allows recruitment of follicles for growth and development
days 5-7
a single follicle develops and begins to produce estradiol which stops menstruation from the previous cycle then signals the pituitary to release LH
ovulation
occurs 24-36 hours after estradiol peak and 10-16 hours after LH spike then the oocyte travels from ovary to fallopian tube
luteal phase
after rupture of follicle and release of the ovum, the remaining follicluar cells become the corpus luteum this synthesizes progesterone, estrogen, and androgens
when looking at coc what should you look at
ethinyl estrogen DOSE and progestin TYPE
1st gen progestins
norethindrone
norethindrone acetate
ethynodiol diacetate
2nd gen progestins
norgestrel
levonorgestrel
3rd gen progestins
desogrestrel
norgestimate
4th gen progestin
drospirenone
estrogen types
ethinyl estradiol (EE)
estradiol validate (EV)
mestranol
estrogen ADE
menstrual irregularity
break through bleeding
N/V (take with food and resolves in a few weeks)
fluid retention –> weight gain and breast tenderness
depression
photosensitivity
increase risk of VTE
progestins work on what receptors
progesterone
androgen
glucocorticoid
1st gen receptors
low progestin
low estrogenic
moderate androgenic
higher risk of unscheduled bleeding and spotting
2nd gen receptors
higher progestin
higher androgenic
levonorgestrel can increase what?
used for what?
may increase cholesterol
may increase androgenic side effects
used for heavy menstrual bleeding
used in planB and IUDs
norgestrel for?
may help with endometriosis